265 related articles for article (PubMed ID: 28807235)
21. Commentary on "A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma." Siva S, Pham D, Gill S, Corcoran NM, Foroudi F. Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Victoria, Australia.: BJU Int 2012;110(11 Pt B):E737-43. doi: 10.1111/j.1464-410X.2012.11550.x. [Epub 2012 Oct 29].
Gottschalk A
Urol Oncol; 2014 Apr; 32(3):374-5. PubMed ID: 24679465
[TBL] [Abstract][Full Text] [Related]
22. Stereotactic ablative body radiotherapy for lung cancer.
Franks KN; Jain P; Snee MP
Clin Oncol (R Coll Radiol); 2015 May; 27(5):280-9. PubMed ID: 25746732
[TBL] [Abstract][Full Text] [Related]
23. Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer.
Hannan R; McLaughlin MF; Pop LM; Pedrosa I; Kapur P; Garant A; Ahn C; Christie A; Zhu J; Wang T; Robles L; Durakoglugil D; Woldu S; Margulis V; Gahan J; Brugarolas J; Timmerman R; Cadeddu J
Eur Urol; 2023 Sep; 84(3):275-286. PubMed ID: 36898872
[TBL] [Abstract][Full Text] [Related]
24. Stereotactic ablative body radiosurgery (SABR) or Stereotactic body radiation therapy (SBRT).
Folkert MR; Timmerman RD
Adv Drug Deliv Rev; 2017 Jan; 109():3-14. PubMed ID: 27932046
[TBL] [Abstract][Full Text] [Related]
25. TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II.
Siva S; Chesson B; Bressel M; Pryor D; Higgs B; Reynolds HM; Hardcastle N; Montgomery R; Vanneste B; Khoo V; Ruben J; Lau E; Hofman MS; De Abreu Lourenco R; Sridharan S; Brook NR; Martin J; Lawrentschuk N; Kron T; Foroudi F
BMC Cancer; 2018 Oct; 18(1):1030. PubMed ID: 30352550
[TBL] [Abstract][Full Text] [Related]
26. Breaking barriers: Stereotactic ablative proton and photon radiation therapy for renal cell carcinoma with extensive metastases: A case report.
Ma MW; Wang ZS; Li HZ; Gao XS; Liu C; Ren XY; Zhang WL; Yang KW
Med Dosim; 2024 Spring; 49(1):41-45. PubMed ID: 37563017
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy?
Widder J; Klinkenberg TJ; Ubbels JF; Wiegman EM; Groen HJ; Langendijk JA
Radiother Oncol; 2013 Jun; 107(3):409-13. PubMed ID: 23773410
[TBL] [Abstract][Full Text] [Related]
28. Disease volume and distribution as drivers of treatment decisions in metastatic prostate cancer: From chemohormonal therapy to stereotactic ablative radiotherapy of oligometastases.
Saluja R; Cheung P; Zukotynski K; Emmenegger U
Urol Oncol; 2016 May; 34(5):225-32. PubMed ID: 27008982
[TBL] [Abstract][Full Text] [Related]
29. Stereotactic body radiation therapy for kidney cancer. Where do we stand?
Sosa-Fajardo P; Blanco-Suarez JM; Pineda-Munguía Á; Rubí-Olea L; Peleteiro-Higuero P; Gajate P; Zafra-Martín J; Siva S; Bossi A; López-Campos F; Couñago F
Int J Urol; 2023 May; 30(5):437-445. PubMed ID: 36746747
[TBL] [Abstract][Full Text] [Related]
30. Role of Radiation in Treatment of Renal Cell Carcinoma.
Leeman JE
Hematol Oncol Clin North Am; 2023 Oct; 37(5):921-924. PubMed ID: 37246085
[TBL] [Abstract][Full Text] [Related]
31. Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose-response relationship.
Siva S; Jackson P; Kron T; Bressel M; Lau E; Hofman M; Shaw M; Chander S; Pham D; Lawrentschuk N; Wong LM; Goad J; Foroudi F
Radiother Oncol; 2016 Mar; 118(3):540-6. PubMed ID: 26873790
[TBL] [Abstract][Full Text] [Related]
32. The promising role of radiotherapy in the treatment of advanced or metastatic renal cell carcinoma: a narrative review.
Wei Q; He H; Lv L; Xu X; Sun W
Transl Androl Urol; 2020 Dec; 9(6):2821-2830. PubMed ID: 33457253
[TBL] [Abstract][Full Text] [Related]
33. Stereotactic Ablative Radiation (SAbR) for Oligometastatic RCC.
All S; Garant A; Hannan R
Semin Radiat Oncol; 2021 Jul; 31(3):227-234. PubMed ID: 34090649
[TBL] [Abstract][Full Text] [Related]
34. Radiation Therapy in the Treatment of Localized and Advanced Renal Cancer.
Yim K; Leeman JE
Urol Clin North Am; 2023 May; 50(2):325-334. PubMed ID: 36948675
[TBL] [Abstract][Full Text] [Related]
35. Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.
Ranck MC; Golden DW; Corbin KS; Hasselle MD; Liauw SL; Stadler WM; Hahn OM; Weichselbaum RR; Salama JK
Am J Clin Oncol; 2013 Dec; 36(6):589-95. PubMed ID: 22868242
[TBL] [Abstract][Full Text] [Related]
36. A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma.
Correa RJM; Ahmad B; Warner A; Johnson C; MacKenzie MJ; Pautler SE; Bauman GS; Rodrigues GB; Louie AV
Radiat Oncol; 2018 Mar; 13(1):47. PubMed ID: 29558966
[TBL] [Abstract][Full Text] [Related]
37. New Strategies in Stereotactic Radiotherapy for Oligometastases.
Palma DA; Louie AV; Rodrigues GB
Clin Cancer Res; 2015 Dec; 21(23):5198-204. PubMed ID: 26626571
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer.
Abbas G; Danish A; Krasna MJ
Surg Oncol Clin N Am; 2016 Jul; 25(3):553-66. PubMed ID: 27261915
[TBL] [Abstract][Full Text] [Related]
39. State of the Art: Multidisciplinary Management of Oligometastatic Renal Cell Carcinoma.
Dason S; Lacuna K; Hannan R; Singer EA; Runcie K
Am Soc Clin Oncol Educ Book; 2023 May; 43():e390038. PubMed ID: 37253211
[TBL] [Abstract][Full Text] [Related]
40. Single-Fraction Stereotactic Ablative Body Radiotherapy for Primary and Extracranial Oligometastatic Cancers.
Greenwood H; Hassan J; Fife K; Ajithkumar TV; Thippu Jayaprakash K
Clin Oncol (R Coll Radiol); 2023 Dec; 35(12):773-786. PubMed ID: 37852814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
